BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33145294)

  • 1. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.
    Zhang N; Bai H; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
    Ann Transl Med; 2020 Sep; 8(17):1075. PubMed ID: 33145294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database.
    Zhang N; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
    Int J Surg; 2020 Feb; 74():44-52. PubMed ID: 31874262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system.
    Deng J; Liu J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
    Chin J Cancer Res; 2018 Oct; 30(5):477-491. PubMed ID: 30510359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
    Liang W; He J; Shen Y; Shen J; He Q; Zhang J; Jiang G; Wang Q; Liu L; Gao S; Liu D; Wang Z; Zhu Z; Ng CS; Liu CC; Petersen RH; Rocco G; D'Amico T; Brunelli A; Chen H; Zhi X; Liu B; Yang Y; Chen W; Zhou Q; He J
    J Clin Oncol; 2017 Apr; 35(11):1162-1170. PubMed ID: 28029318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal examined lymph node number for accurate staging and long-term survival in rectal cancer: a population-based study.
    Guan X; Jiao S; Wen R; Yu G; Liu J; Miao D; Wei R; Zhang W; Hao L; Zhou L; Lou Z; Liu S; Zhao E; Wang G; Zhang W; Wang X
    Int J Surg; 2023 Aug; 109(8):2241-2248. PubMed ID: 37428195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    Dong Y; Qiu Y; Deng J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):515-528. PubMed ID: 31813005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
    Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.
    Jiao XG; Deng JY; Zhang RP; Wu LL; Wang L; Liu HG; Hao XS; Liang H
    World J Gastroenterol; 2014 Apr; 20(13):3640-8. PubMed ID: 24707149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the number of examined lymph nodes on stage migration in node-negative gastric cancer patients: a Chinese multi-institutional analysis with propensity score matching.
    Gu P; Deng J; Wang W; Wang Z; Zhou Z; Xu H; Liang H
    Ann Transl Med; 2020 Aug; 8(15):938. PubMed ID: 32953738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study.
    MingHua Z; KeCheng Z; ZhenYu C; Lin C; ChunXi W; ZeLong Y
    J Gastrointest Surg; 2021 Apr; 25(4):919-925. PubMed ID: 32318943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Examined Lymph Node Number in Accurate Staging and Enhanced Survival in Resected Gastric Adenocarcinoma-The More, the Better? A Cohort Study of 8,696 Cases From the US and China, 2010-2016.
    Huang L; Zhang X; Wei Z; Xu A
    Front Oncol; 2020; 10():539030. PubMed ID: 33585181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative Lymph Node Is an Independent Prognostic Factor for Stage III Gastric Cancer Patients After Curative Gastrectomy: A Surveillance, Epidemiology, and End Results-Based Study.
    Liu L; Ren J; Wang G; Cui Y; Li F; Wang D; Lei X
    Am Surg; 2023 Nov; 89(11):4413-4423. PubMed ID: 35861326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of examined lymph node number on lymph node status and prognosis in FIGO stage IB-IIA cervical squamous cell carcinoma: A population-based study.
    Yong J; Ding B; Dong Y; Yang M
    Front Oncol; 2022; 12():994105. PubMed ID: 36203444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of the Number of Lymph Nodes Examined in Patients with Node-Negative Gastric Cancer.
    Yang ZL; Zhu MH; Shi Q; Lu FM; Wang CX
    J Gastrointest Surg; 2019 Mar; 23(3):460-467. PubMed ID: 30225793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of examined lymph node number on accurate nodal staging and long-term survival of resected Siewert type II-III adenocarcinoma of the esophagogastric junction: A large population-based study.
    Ding B; Yong J; Zhang L; Luo P; Song E; Rankine AN; Wei Z; Wang X; Xu A
    Front Oncol; 2022; 12():979338. PubMed ID: 36387223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
    Yuan SQ; Chen YT; Huang ZP
    J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
    Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
    Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of examined lymph node count in older patients with stage T1N0M0 pulmonary carcinoid tumours: a population-based propensity score-matched analysis.
    Yang H; Fang Z; Liu T; Zhu X; Luo L
    Aging Clin Exp Res; 2023 Jan; 35(1):203-212. PubMed ID: 36319940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
    Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
    BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.